Plain-English translation of NCT07150624 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether polyene phosphatidylcholine injection, given before and after liver surgery, can better protect the liver and help it recover compared to standard care alone. Patients with liver cancer who need laparoscopic (minimally invasive) surgery to remove part of their liver will receive either the new medication combined with standard treatment, or standard treatment alone. The goal is to see if this additional medication reduces liver damage after surgery.
When surgeons remove part of the liver for cancer, the remaining liver can sometimes be injured during the operation. This medication has been used to support liver health, and researchers want to find out if using it before and after surgery can better prevent or reduce this injury and help patients recover faster.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to one of two groups. Both groups will have laparoscopic liver surgery for cancer. One group will receive polyene phosphatidylcholine injections starting the day before surgery (twice daily) and continuing for 5 days after surgery (twice daily), along with standard supportive care. The other group will receive only the standard supportive care for 5 days after surgery. Doctors will monitor your liver function through blood tests and compare how well each group recovers.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
China